ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 299

Bik Plays an Important Role of Cell Proliferation Caused By Nitric Oxide in Rheumatoid Arthritis Synovium

Takeshi Ueha1, Yoshitada Sakai1, Kohjin Suzuki2, Koji Fukuda3, Toshihisa Maeda3, Hanako Nishimoto3, Shinya Hayashi4, Yasushi Miura4, Ryosuke Kuroda3 and Akira Hashiramoto2, 1Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 2Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 3Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan, 4Orthpaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Apoptosis, Cell Signaling, Inflammation, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Nitric oxide (NO), a proinflammatory mediator responsible for various physiological processes, plays a central role in the pathogenesis of rheumatoid arthritis (RA). As a heme-based sensor for NO, a transcription factor neuronal PAS domain protein 2 (NPAS2) forms a heterodimer with clock gene BMAL1. Using RA fibroblast-like synoviocytes (-FLS), we previously reported the interaction of clock genes and Bcl-2-interacting killer (BIK) which was known to be an inducer of mitochondrial apoptosis, and the promoter site of BIK has the NPAS2/BMAL1 heterodimer binding enhanced box sites (E-box sites). In this study, we evaluated the role of NPAS2 in RA synovium in views of relationship between NO and BIK.

Methods: The synovium were obtained during total knee replacement surgery from patients. Immunohistochemistry was performed to determine NPAS2 expression in synovial tissue. Cell proliferation was assessed with WST-8 assay in RA-FLS, using varying concentrations of the NO donor, S-Nitroso-N-acetyl-DL-penicillamine (SNAP) (0-20 nM). To evaluate the relationship between NPAS2 and BIK, NPAS2-siRNA was used to measure BIK mRNA expression in the absence and presence (5, 20 nM) of SNAP in RA-FLS. Moreover, we cloned the three BIK promoters (see Figure1), made luciferase assay model, and measured the luciferase activity in the absence and presence of SNAP in RA-FLS.

Results: NPAS2 expression was observed in RA synovium. Cell proliferation was significantly increased by SNAP. In the presence of SNAP, BIK mRNA expression was significantly reduced in the control-siRNA group, but not in the NPAS2-siRNA group (Figure 2, *; P < 0.05). In the presence of SNAP, the luciferase activity was significantly reduced in the Bik-E2-promoter group, but not in the Bik-E0-promoter group (Figure 3, *; P < 0.05).

Conclusion: NPAS2 enhance Bik expression, and NO inhibited Bik expression by NPAS2. These results suggests that NO may inhibit NPAS2 to bind E-box of Bik promoter. We propose a novel action of NO that inhibits mitochondrial apoptosis of RA-FLS by preventing the binding between NPAS2 and BIK. Therefore, we suggested that the inhibition of NO and NPAS2 may clinically be potential of anti-hyperproliferation and anti-bone destruction in RA synovium.



Disclosure: T. Ueha, None; Y. Sakai, None; K. Suzuki, None; K. Fukuda, None; T. Maeda, None; H. Nishimoto, None; S. Hayashi, None; Y. Miura, None; R. Kuroda, None; A. Hashiramoto, None.

To cite this abstract in AMA style:

Ueha T, Sakai Y, Suzuki K, Fukuda K, Maeda T, Nishimoto H, Hayashi S, Miura Y, Kuroda R, Hashiramoto A. Bik Plays an Important Role of Cell Proliferation Caused By Nitric Oxide in Rheumatoid Arthritis Synovium [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/bik-plays-an-important-role-of-cell-proliferation-caused-by-nitric-oxide-in-rheumatoid-arthritis-synovium/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bik-plays-an-important-role-of-cell-proliferation-caused-by-nitric-oxide-in-rheumatoid-arthritis-synovium/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology